Studies have shown that ESPR1 and RBM5 play an important role in the event of alternative splicing in cancer 42, 43, and the results of GESA also show that ESRP1 and RBM5 are significantly enriched in the spliceosome pathway. The gene discussed is ESRP1; the disease is cancer.